Pleo Oryzae (Sanum Kehlbeck GmbH & Co. KG)


Welcome to the PulseAid listing for the Pleo Oryzae drug offered from Sanum Kehlbeck GmbH & Co. KG. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Sanum Kehlbeck GmbH & Co. KG
NON-PROPRIETARY NAME: aspergillus flavus var. oryzae
SUBSTANCE NAME: ASPERGILLUS FLAVUS VAR. ORYZAE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: SOLUTION/ DROPS
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2010-06-15
END MARKETING DATE: 0000-00-00


Pleo Oryzae HUMAN OTC DRUG Details:

Item DescriptionPleo Oryzae from Sanum Kehlbeck GmbH & Co. KG
LABELER NAME: Sanum Kehlbeck GmbH & Co. KG
DEA SCHEDULE:
ACTIVE STRENGTH: 6([hp_X]/10mL)
START MARKETING DATE: 2010-06-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 60681-0021_15f8962a-0abe-42cf-9766-15d8508ba34d
PRODUCT NDC: 60681-0021
APPLICATION NUMBER:

Other ASPERGILLUS FLAVUS VAR. ORYZAE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Sanum Kehlbeck GmbH & Co. KGPleo Oryzae